TWM
NVO

Tripletail Wealth Management’s Novo Nordisk NVO Stock Holding History

Tripletail Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.61K Sell
131
-27
-17% -$1.16K 0.01% 244
2026
Q1 		$5.84K Sell
158
-11
-7% -$521 0.01% 224
2025
Q4 		$8.6K Sell
169
-27
-14% -$1.38K 0.01% 216
2025
Q3 		$11.6K Buy
+196
New +$11.5K 0.01% 251

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Tripletail Wealth Management's NVO Position: Q2 2026 in Review

Tripletail Wealth Management reduced its Novo Nordisk (NVO) stake by 17% in Q2 2026, selling an estimated $1.16K and leaving 131 shares worth $6.61K. The position accounts for 0.01% of the portfolio, ranked #244.

Tripletail Wealth Management first reported a position in NVO in Q3 2025 and has held it in 4 quarters since. The position peaked at $11.6K in Q3 2025. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Tripletail Wealth Management held 131 shares of Novo Nordisk worth $6.61K as of Q2 2026.
  • Tripletail Wealth Management sold 27 Novo Nordisk shares in Q2 2026, an estimated $1.16K.
  • Novo Nordisk made up 0.01% of Tripletail Wealth Management's portfolio in Q2 2026, its #244 holding.
  • Tripletail Wealth Management first reported a position in Novo Nordisk in Q3 2025 and has held it in 4 quarters since.
  • Tripletail Wealth Management's Novo Nordisk position peaked at $11.6K in Q3 2025.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Tripletail Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.